Optiscan Imaging

Optiscan Imaging EV/Revenue

The EV/Revenue (Enterprise Value to Revenue) of Optiscan Imaging (OIL.AX) as of Nov 4, 2026 is 168.79. In the previous year, EV/Revenue (Enterprise Value to Revenue) was 23.01 — a change of 633.64% (higher).

EV/Revenue

168.79

YoY

633.64%

Last updated:

EV/Revenue (Enterprise Value to Revenue) of Optiscan Imaging is 2026 168.79 . EV/Revenue (Enterprise Value to Revenue) of Optiscan Imaging was 2025 23.01 . It decreases by 633.64% higher compared to the previous year.

The Optiscan Imaging EV/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/Revenue
Date
EV/Revenue
Jan 1, 2019
65.96 AUD
Jan 1, 2020
75.07 AUD
Jan 1, 2021
91.04 AUD
Jan 1, 2022
83.71 AUD
Jan 1, 2023
52.55 AUD
Jan 1, 2024
67.28 AUD
Jan 1, 2025
23.01 AUD
Jan 1, 2026
168.79 AUD
The Optiscan Imaging EV/Revenue history
YEAREV/RevenueYoY
168.79+633.64%
23.01-65.80%
67.28+28.02%
52.55-37.22%
83.71-8.05%
91.04+21.27%
75.07+13.82%
65.96+124.46%
29.38-55.51%
66.04-77.00%
287.13-83.03%
1,692.21+61.35%
1,048.77—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Optiscan Imaging Stock analysis

What does Optiscan Imaging do? Optiscan Imaging Ltd is an Australian company specializing in the development and commercialization of advanced imaging technologies. The company was founded in 1994 and is headquartered in Notting Hill, a suburb of Melbourne. Optiscan was originally established as a spin-off company from Monash University to enable the commercial application of a groundbreaking technology called confocal microscopy. However, over the years, the company has expanded into other imaging technologies and now offers a wide range of products and services. Optiscan's business model involves developing and bringing to market innovative technologies that can be used in biomedical research and clinical diagnostics. The company works closely with research institutions and companies in various industries to develop customized imaging solutions. Optiscan offers a wide range of products, including confocal microscopes, multiphotonic microscopes, real-time imaging systems, and Raman spectrometers. These products are used in various application areas such as cancer research, neurobiology, cell biology, and materials science. Another important area for Optiscan is veterinary imaging. The company has developed a product line for veterinary medicine that is used by veterinarians and researchers around the world. Optiscan's imaging systems enable veterinarians to obtain precise and detailed images of animals to enable better diagnosis and treatment. Optiscan also operates a service department that offers customized imaging solutions to customers. The company provides services such as image processing, data analysis, and prototype development. Overall, Optiscan has become one of the leading providers of imaging technologies in Australia and globally over the past decades. The company has a long history of collaboration with leading research institutions and companies worldwide and remains committed to developing innovative solutions for the challenges of biomedicine and imaging. Optiscan Imaging is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Optiscan Imaging stock

EV/Revenue (Enterprise Value to Revenue) of Optiscan Imaging is 168.79 in 2026.

EV/Revenue (Enterprise Value to Revenue) of Optiscan Imaging changed from 23.01 to 168.79, representing a 633.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/Revenue (Enterprise Value to Revenue) Optiscan Imaging since 2006 – with annual values, charts, and detailed analysis.

The EV/Revenue ratio compares a company's enterprise value to its total revenue. It is particularly useful for valuing high-growth companies that may not yet be profitable.

To evaluate EV/Revenue (Enterprise Value to Revenue)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/Revenue (Enterprise Value to Revenue).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/Revenue (Enterprise Value to Revenue)'s Optiscan Imaging with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Optiscan Imaging

All Key Metrics — Optiscan Imaging